| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000006808 |
| Receipt No. | R000007749 |
| Official scientific title of the study | A randomized controlled trial of lanthanum carbonate versus calcium carbonate on coronary artery calcification in patients new to dialysis |
| Date of disclosure of the study information | 2011/12/01 |
| Last modified on | 2017/10/30 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | A randomized controlled trial of lanthanum carbonate versus calcium carbonate on coronary artery calcification in patients new to dialysis | |
| Title of the study (Brief title) | Effect of lanthanum carbonate on coronary artery calcification in patients new to dialysis | |
| Region |
|
|
| Condition | ||
| Condition | End-stage renal disease (at the induction of dialysis) | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To determine the effect of lanthanum carbonate on coronary artery calcification in patients new to dialysis |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Changes of coronary artery calcification score (Agatston score) |
| Key secondary outcomes | echocardiography, heart valve calcification, aortic calcification, vascular stiffness, carotid IMT, bone density, bone metabolic markers, ADMA, oxidative stress, high-sensitive CRP |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | lanthanum carbonate | |
| Interventions/Control_2 | calcium carbonate | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients new to hemodialysis with hyperphosphatemia | |||
| Key exclusion criteria | 1)Patients who have contraindication to lanthanum carbonate or calcium carbonate
2)Patients with history of parathyroidectomy 3)Gastrointestinal disorder 4)Patients with history of illeus 5)CAPD(continuous ambulatory peritoneal dialysis) 6)Pregnant and breast-feeding 7)Patients judged as being inappropriate for this study by investigators |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Shinichi Nishi |
| Organization | Kobe university graduate school of medicine |
| Division name | Division of nephrology and kidney Center |
| Address | 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan |
| TEL | (078)382-6500 |
| snishi@med.kobe-u.ac.jp | |
| Public contact | |
| Name of contact person | Hideki Fujii |
| Organization | Kobe university graduate school of medicine |
| Division name | Division of nephrology and kidney center |
| Address | 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan |
| TEL | (078)382-6500 |
| Homepage URL | |
| fhideki@med.kobe-u.ac.jp | |
| Sponsor | |
| Institute | Division of nephrology & kidney center, Kobe university graduate school of medicine. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Division of nephrology and kidney center, Kobe university graduate school of medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | Bayer,The kidney foundation Japan |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 千船病院、甲南病院、六甲アイランド病院、明石医療センター、西脇市立病院、高砂市民病院、城陽江尻病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | https://link.springer.com/article/10.1007%2Fs00223-017-0347-3 |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007749 |